Publications by authors named "A N Vlasova"

Age-related macular degeneration (AMD) is a chronic multifactorial degenerative eye disease and one of the leading causes of irreversible blindness worldwide. Despite extensive research, there is no consensus on the predominant pathological mechanism leading to photoreceptor death. AMD is associated with molecular and cellular disruptions that ultimately result in photoreceptor degeneration.

View Article and Find Full Text PDF

Naphthalene is a fungicide that can also be a phase-change agent owing to its high crystallization enthalpy at about 80 °C. The relatively rapid evaporation of naphthalene as a fungicide and its shape instability after melting are problems solved in this work by its placement into a cured epoxy matrix. The work's research materials included diglycidyl ether of bisphenol A as an epoxy resin, 4,4'-diaminodiphenyl sulfone as its hardener, and naphthalene as a phase-change agent or a fungicide.

View Article and Find Full Text PDF

It is well known that the number of true truffles in the wild is decreasing. The aim of the study was to develop an effective, simple and affordable method of asci disruption to release black truffle spores. It was shown that the spore release can be achieved by different ways, such as mechanical or biological destruction.

View Article and Find Full Text PDF
Article Synopsis
  • Rotavirus A (RVA) is a leading cause of gastroenteritis in calves and has the potential to spread to humans, making it a public health concern.
  • A study in Amhara, Ethiopia, involved 266 calves to assess the prevalence and genetic variety of RVA, finding a 15.4% infection rate with various G and P genotypes.
  • The research highlights the need for ongoing monitoring of RVA in calves due to its significant presence and possible zoonotic transmission risks.
View Article and Find Full Text PDF

The management of heart failure with preserved ejection fraction (HFpEF) remains largely unresolved due to our limited understanding of the underlying mechanisms of the pathology and the challenges in accurately phenotyping this heterogeneous syndrome. A paradigm shift is required to personalise care and unify our approaches to HFpEF patients for future clinical trials. Accordingly, we propose a staging classification for HFpEF based on the identification of the involved cardiac chambers by echocardiography.

View Article and Find Full Text PDF